Literature DB >> 28573775

ISUOG updated consensus statement on the impact of cfDNA aneuploidy testing on screening policies and prenatal ultrasound practice.

L J Salomon1, Z Alfirevic2, F Audibert3, K O Kagan4, D Paladini5, G Yeo6, N Raine-Fenning7.   

Abstract

Mesh：

Substances：

Year:  2017        PMID： 28573775     DOI： 10.1002/uog.17483

Source DB:  PubMed          Journal:  Ultrasound Obstet Gynecol        ISSN： 0960-7692            Impact factor:   7.299


× No keyword cloud information.
  18 in total

Review 1.  Screening for fetal chromosomal and subchromosomal disorders.

Authors:  Sarah Harris; Dallas Reed; Neeta L Vora
Journal:  Semin Fetal Neonatal Med       Date:  2017-11-08       Impact factor: 3.926

2.  Isolated 'soft signs' of fetal choroid plexus cysts or echogenic intracardiac focus - consequences of their continued reporting.

Authors:  Grace Prentice; Alec Welsh; Amy Howat; Dominic Ross; Amanda Henry
Journal:  Australas J Ultrasound Med       Date:  2019-10-11

3.  Isochromosome 21q is overrepresented among false-negative cell-free DNA prenatal screening results involving Down syndrome.

Authors:  Karin Huijsdens-van Amsterdam; Lieve Page-Christiaens; Nicola Flowers; Michael D Bonifacio; Katie M Battese Ellis; Ida Vogel; Else Marie Vestergaard; Javier Miguelez; Mario Henrique Burlacchini de Carvalho; Erik A Sistermans; Mark D Pertile
Journal:  Eur J Hum Genet       Date:  2018-06-13       Impact factor: 4.246

4.  Noninvasive Prenatal Testing for Trisomies 21, 18, and 13, Sex Chromosome Aneuploidies, and Microdeletions: A Health Technology Assessment.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2019-02-19

5.  The Use of Ultrasound as a Potential Adjunct to Cell-Free Fetal DNA Screening for Aneuploidy at Weill Cornell Medical College, New York, USA.

Authors:  Jessica Scholl; Stephen Chasen
Journal:  Surg J (N Y)       Date:  2018-02-09

6.  Clinical performance of DNA-based prenatal screening using single-nucleotide polymorphisms approach in Thai women with singleton pregnancy.

Authors:  Tachjaree Panchalee; Naravat Poungvarin; Warisa Amornrit; Julaporn Pooliam; Pattarawalai Taluengjit; Tuangsit Wataganara
Journal:  Mol Genet Genomic Med       Date:  2020-04-24       Impact factor: 2.183

7.  Nuchal translucency of 3.0-3.4 mm an indication for NIPT or microarray? Cohort analysis and literature review.

Authors:  Olav B Petersen; Eric Smith; Diane Van Opstal; Marike Polak; Maarten F C M Knapen; Karin E M Diderich; Caterina M Bilardo; Lidia R Arends; Ida Vogel; Malgorzata I Srebniak
Journal:  Acta Obstet Gynecol Scand       Date:  2020-05-12       Impact factor: 3.636

8.  Targeted fetal cell-free DNA screening for aneuploidies in 4,594 pregnancies: Single center study.

Authors:  Altug Koc; Ozge Ozer Kaya; Berk Ozyilmaz; Yasar B Kutbay; Ozgur Kirbiyik; Taha R Ozdemir; Kadri M Erdogan; Merve Saka Guvenc; Deniz C Oztekin; Mehmet Ozeren; Halil G Pala; Atalay Ekin; Cenk Gezer; Alkim G Sahingoz Yildirim; Bahar Konuralp Atakul; Secil Kurtulmus; Ugur Turhan; Cuneyt E Taner
Journal:  Mol Genet Genomic Med       Date:  2019-05-08       Impact factor: 2.183

9.  Differential expression profile study and gene function analysis of maternal foetal-derived circRNA for screening for Down's syndrome.

Authors:  Weiguo Sui; Qing Gan; Yan Chang; Minglin Ou; Jiejing Chen; Hua Lin; Wen Xue; Yan Wu; Huiyan He; Donge Tang; Yong Dai
Journal:  Exp Ther Med       Date:  2019-12-05       Impact factor: 2.447

10.  Impact of ultrasonography on identifying noninvasive prenatal screening false-negative aneuploidy.

Authors:  Wei Li; Fanwei Zeng; Baitong Fan; Nan Yu; Jing Wu; Yun Yang; Hui Huang; Sheng-Li Li; Zhiyu Peng
Journal:  Mol Genet Genomic Med       Date:  2020-03-21       Impact factor: 2.183
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.